Humana AB (HUM) Fair Value & Analysis
Healthcare · SE · Market cap 2.3B SEK
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 5 days ago
Share price +19.7% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 24.40 – kr 46.80 · fair‑value band kr 82.29 – kr 137.15 · the kr 46.80 price screens below the kr 109.72 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Humana AB (HUM) currently trades at kr 46.80, while our model-based Fair Value estimate is kr 109.72 — implying the stock looks roughly 134.4% undervalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Humana AB generated revenue of 10.0B SEK at a net margin of 2.0%. Revenue declined 2.3% year over year. It earns a return on equity of 6.1%. Net debt stands at 6.4B SEK. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. The company operates through three segments: Sweden, Finland, and Norway. It provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; family care services; short-term, short term housing, day care, and special service housing; outpatient care; assisted living homes; and specially adapted housing for individuals with functional impairments. The company also offers care services and assistance to individuals with permanent functional impairments. In addition, it provides elderly care home services, special service housing, and personal assistance to individuals with permanent functional impairments. Humana AB (publ) was founded in 2001 and is headquartered in Stockholm, Sweden.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Humana AB reported revenue of kr 10.0B in FY2025 versus kr 8.2B in FY2021, a compound +5.2%/yr. Reported net income was kr 237M in FY2025, compounding −3.7%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Tenet Healthcare Corporation THC | $164.77 | $280.85 | +70% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Humana AB (HUM) undervalued?
What is the fair value of HUM?
What is the quality score of HUM?
What is the revenue of Humana AB (HUM)?
What is the net profit margin of HUM?
Does Humana AB pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.